How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna July 22, 2021 · by Aviatior · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. · https://www.cnbc.com/amp/2021/06/30/how-crispr-gene-editing-will-treat-disease-intellia-founder-doudna-.html Share this:Share on TumblrTweetWhatsAppTelegramEmailPrintMorePocketLike this:Like Loading... Related